Literature DB >> 25119351

Feline patent Toxoplasma-like coccidiosis among feral cats (Felis catus) in Doha city, Qatar and its immediate surroundings.

Marawan A Abu-Madi1, Jerzy M Behnke.   

Abstract

Doha city has a high feral cat population and studies of hospital records in Doha have shown that human toxoplasmosis also occurs. Clearly, there is a need to understand the role of cats as vectors of human toxoplasmosis in the city and as a first step we assessed the extent of patent Toxoplasma-like coccidial infections among feral cats. Oocysts in cat faeces were detected between June 2008 and April 2010, from a range of locations radiating out of the city centre in concentric semi circular/elliptic rings and by north, west and south divisions within each of the rings. In total 4,652 cats were sampled and overall prevalence of oocysts was 9.1%. Prevalence was 10.1% in the first summer, and then dropped to 8.4% in the following winter and further to 6.8% in the next summer before rising to 10.6% in the final winter of the study; this interaction between annual period and season was significant. There were also significant changes in prevalence across each of the consecutive months of the study, but no clear pattern was evident. Prevalence did not vary significantly by city sector and there was no difference in prevalence between the host sexes. We conclude therefore, that despite minor and significant perturbations, the prevalence of patent Toxoplasma-like coccidial infections among cats in Doha is remarkably stable throughout the year, across years and spatially within the city's districts.

Entities:  

Mesh:

Year:  2014        PMID: 25119351     DOI: 10.2478/s11686-014-0254-y

Source DB:  PubMed          Journal:  Acta Parasitol        ISSN: 1230-2821            Impact factor:   1.440


  1 in total

1.  Seroprevalence of Toxoplasma gondii infection in feral cats in Qatar.

Authors:  Sonia Boughattas; Jerzy Behnke; Aarti Sharma; Marawan Abu-Madi
Journal:  BMC Vet Res       Date:  2017-01-18       Impact factor: 2.741

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.